Fig. 1 · Structure
Documents & Downloads
Benzalazine
Anti-Ulcerative Colitis Agent
Benzalazine is a 5-azo derivative of 5-aminosalicylic acid primarily targeting inflammatory pathways involved in ulcerative colitis. It exhibits anti-inflammatory properties, making it useful for research on ulcerative colitis and Crohn's disease affecting the large intestine. The active metabolite, 5-ASA, along with its derivative acetyl-5-aminosalicylic acid, is predominantly excreted via feces, contributing to its therapeutic profile.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 588-68-1 |
| Applications | Anti-Ulcerative Colitis Agent |
| Formula | C14H12N2 |
| Molecular Weight | 208.26 |
| SMILES | C1(/C=N/N=C/C2=CC=CC=C2)=CC=CC=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.